Neutrophil-lymphocyte Ratio and Platelet-lymphocyte Ratio as Predictors for Adverse Events in EVAR
NCT ID: NCT04254211
Last Updated: 2021-04-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
230 participants
OBSERVATIONAL
2016-03-01
2019-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prognostic Impact of NLR, PLR, and MPV in Patients Undergoing AAA Open Repair
NCT05031195
Immediate Management of the Patient With Rupture : Open Versus Endovascular Repair
NCT00746122
Muscle and Cerebral Oxygenation Under EVAR of AAA: GA vs LA
NCT02555046
Contrast Enhanced Ultrasound, Endoleak Detection Following EVAR v1.3
NCT02688751
Endovascular Aneurysm Repair (EVAR) Gate Study
NCT02934087
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
EVAR
Patinets with AAA, treated electively by EVAR. The values of simple inflammatory markers,neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR), were measured pre- and postoperatively. Adverse events included any major adverse cardiovascular events (MACE), acute kidney injury and death from any cause
NLR
neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NLR
neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR)
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Elective
* EVAR
Exclusion Criteria
* Open surgery
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Thessaly
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Elena Arnaoutoglou
Professor of Anesthesiology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elena Arnaoutoglou, MD, PhD
Role: STUDY_CHAIR
University of Thessaly
Maria Ntalouka, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital of Larissa
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Univeristy of Thessaly
Larissa, Thessaly, Greece
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NLR, PLR in EVAR
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.